Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway
about
Competitive regulation of E-cadherin juxtamembrane domain degradation by p120-catenin binding and Hakai-mediated ubiquitination.Ligand binding induces Cbl-dependent EphB1 receptor degradation through the lysosomal pathwaySmall glutamine-rich tetratricopeptide repeat-containing protein (SGT) interacts with the ubiquitin-dependent endocytosis (UbE) motif of the growth hormone receptorAb-induced ectodomain shedding mediates hepatocyte growth factor receptor down-regulation and hampers biological activityNetrin induces down-regulation of its receptor, Deleted in Colorectal Cancer, through the ubiquitin-proteasome pathway in the embryonic cortical neuronCaveolin-1 down-regulates inducible nitric oxide synthase via the proteasome pathway in human colon carcinoma cellsThe Grb10/Nedd4 complex regulates ligand-induced ubiquitination and stability of the insulin-like growth factor I receptorThe F-box protein Rcy1p is involved in endocytic membrane traffic and recycling out of an early endosome in Saccharomyces cerevisiaeA deubiquitinating enzyme UBPY interacts with the Src homology 3 domain of Hrs-binding protein via a novel binding motif PX(V/I)(D/N)RXXKPRYK, a catalytically inactive receptor tyrosine kinase, associates with EphB2 and EphB3 but does not interact with AF-6Normal and malignant prostate epithelial cells differ in their response to hepatocyte growth factor/scatter factorAltered trafficking of membrane proteins in purkinje cells of SCA1 transgenic miceThe processing and utilization of hepatocyte growth factor/scatter factor following partial hepatectomy in the ratProteasomal regulation of betac signaling reveals a novel mechanism for cytokine receptor heterotypic desensitizationGastrointestinal hormones cause rapid c-Met receptor down-regulation by a novel mechanism involving clathrin-mediated endocytosis and a lysosome-dependent mechanismc-Cbl/Sli-1 regulates endocytic sorting and ubiquitination of the epidermal growth factor receptorAssessing the significance of chromosomal aberrations in cancer: methodology and application to gliomaActivation-dependent degradation of protein kinase C eta.Deubiquitinase activities required for hepatocyte growth factor-induced scattering of epithelial cells.Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors.The carboxyl terminus of VEGFR-2 is required for PKC-mediated down-regulationAn iron-regulated and glycosylation-dependent proteasomal degradation pathway for the plasma membrane metal transporter ZIP14Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue.The reduction of Na/H exchanger-3 protein and transcript expression in acute ischemia-reperfusion injury is mediated by extractable tissue factor(s)Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins.Met/Hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation.Structure and regulation of opioid receptors.Overexpression of sprouty 2 inhibits HGF/SF-mediated cell growth, invasion, migration, and cytokinesis.Ubiquitination-dependent regulation of signaling receptors in cancer.Kaposi's sarcoma-associated herpesvirus K3 utilizes the ubiquitin-proteasome system in routing class major histocompatibility complexes to late endocytic compartments.Cbl-transforming variants trigger a cascade of molecular alterations that lead to epithelial mesenchymal conversionAnterograde trafficking of KCa3.1 in polarized epithelia is Rab1- and Rab8-dependent and recycling endosome-independentHormone binding induces rapid proteasome-mediated degradation of thyroid hormone receptors.The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US11 gene productsIdentification of a novel MET mutation in high-grade glioma resulting in an auto-active intracellular proteinHGF/SF-Met signaling in tumor progression.The tyrosine kinase regulator Cbl enhances the ubiquitination and degradation of the platelet-derived growth factor receptor alpha.Constitutive proteolysis of the ErbB-4 receptor tyrosine kinase by a unique, sequential mechanism.Involvement of the ubiquitin/proteasome system in sorting of the interleukin 2 receptor beta chain to late endocytic compartmentsThe tyrosine kinase c-Met contributes to the pro-tumorigenic function of the p38 kinase in human bile duct cholangiocarcinoma cells
P2860
Q21134566-A97ADF3D-03FE-4BCD-979B-698F9463997DQ24301313-C04D231B-58FE-4743-9B9A-4CC09DF52892Q24530121-A1B6673D-2348-4485-B9FF-C866340B55B6Q24546366-1B32A441-A141-413B-8C76-3C9511180448Q24641839-FACB7FE0-0B33-4F8B-BE96-88665A463753Q24672900-26004DD5-CD1D-4EAA-B94F-3402249143A4Q24682781-B190BC4C-0C72-4755-9F60-6E7D2AB43C29Q27931511-615FA186-36DB-4C0E-A3AB-4E1B88108911Q28138440-D78FDDD7-511B-48FC-B96C-A5F5B58234E8Q28214910-0894C200-80D1-4310-BE04-723978A2094BQ28345285-382011CD-FA7C-4097-9893-35CD894CBD24Q28350690-1A958436-7F75-405F-BCC1-23E6FC488B0EQ28360983-F9142C53-2632-4262-BD62-0E52B113484EQ28366655-1348F75A-096A-4A7B-A74A-809FE8DC402AQ28570307-84B918BE-F22B-4BB7-9E07-B975DAF9E32DQ29618661-801DF8A7-F426-49B3-AE03-5C4B2E32C31CQ30014823-F800143C-E839-4C18-9716-7C05AF1061F9Q30306040-3046A285-7193-4594-9E0F-87BDCDF2E840Q30872503-9362959E-C4B3-4926-9A70-D83888993EB2Q31816606-9C33ABB7-6D7D-447D-942B-2D78BA88E498Q33734632-2253B1D7-CDE5-4E13-9DAF-C0611F1A32C5Q33835287-6E595767-3D8C-4B84-8526-86FD52AC841EQ33901677-0F2F06AE-52B4-40E1-827A-7C01822DA144Q33924218-C72EA52E-1CB8-40FC-9E5A-DC38E095490AQ33944128-0809F860-6F25-4EB1-8F54-E2A733FE4F86Q34097397-36565B0A-833E-4F68-8E56-61340FE53700Q34136307-D7893BF8-B13A-4487-B159-A9F670AC83D6Q34318050-C40C29F8-A6BD-4741-B2FE-800EF7C029B3Q34365210-EAC4193C-B1F5-4841-AB89-44F181D72961Q34365965-E38C1C91-D9D1-45A9-9DE0-3DA16EC0EACEQ34764852-87CA35CC-F8DF-483F-A5E8-8E9FBB0CBF97Q35121704-C1A2AB89-00FD-4A27-B6BA-CC222B32E804Q35192645-7D2B88CC-7E3C-4711-8553-99D72A9186B8Q35553472-19925F2F-DF89-49C1-8CD7-C4F92345E27BQ35747784-90AD3067-8BA9-4298-94ED-6EEFF3B3B66FQ36027374-A30F404B-DBE0-48B4-A2BF-FFD693021E2BQ36164471-3252A755-1C02-4F0B-A651-859A177BB124Q36274343-BD2F989C-A872-4C2B-AB06-4163D48D73C9Q36280110-12DB59BB-D206-417C-837B-881FBC93DC1DQ36407783-DD1DFA22-8137-46C6-8CCC-655EC383E338
P2860
Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway
@ast
Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway
@en
type
label
Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway
@ast
Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway
@en
prefLabel
Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway
@ast
Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway
@en
P2093
P2860
P356
P1476
Degradation of the Met tyrosine kinase receptor by the ubiquitin-proteasome pathway
@en
P2093
Vande Woude GF
Weidner KM
P2860
P304
P356
10.1128/MCB.17.2.799
P407
P577
1997-02-01T00:00:00Z